We herein present an overview of the upcoming 5 th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

To define specific pathways important in the multistep transformation process of normal
plasma cells (PCs) to monoclonal gammopathy of uncertain significance (MGUS) and multiple …

Purpose In chronic lymphocytic leukemia (CLL), TP53 deletion/mutation is strongly associated
with an adverse outcome and resistance to chemotherapy-based treatment. In contrast, …

Objective Rituximab appears to be effective in many studies of systemic lupus erythematosus
(SLE), with variable initial clinical response and time to relapse. However, results of a …

… D., Andrew Rawstron, Ph.D., Piers EM Patten, Ph.D., FRCP, and Peter Hillmen, MB, Ch.…
Hillmen P, Rawstron AC, Brock K, et al. Ibrutinib plus venetoclax in relapsed/ refractory chronic …

The aim of this study was to develop a flow cytometric test to quantitate low levels of circulating
myeloma plasma cells, and to determine the relationship of these cells with disease stage…

Within the contemporary multitude of complex methods used in clinical flow cytometry, very
few techniques exist which can be described as disease‐specific diagnostic tests. Detection …

Assessment of measurable residual disease (often referred to as “minimal residual disease”)
has emerged as a highly sensitive indicator of disease burden during and at the end of …

The reduced levels of normal immunoglobulin in patients with myeloma may be due to
suppression of normal B‐cell differentiation. However, reports on the numbers of B cells vary, with …

PURPOSE: To determine the effect of polymorphic variations in the tumor necrosis factor
alpha (TNFα) and lymphotoxin alpha (LTα) genes on the predisposition to myeloma and the …